Literature DB >> 26858482

A case of idiopathic choroidal neovascular membrane in a young patient.

M A Khan1, Shabnam Bhalla2, V S Gurunadh3, V K Mohindra4, Sridhara Reddy2.   

Abstract

Entities:  

Keywords:  Idiopathic CNV; Ranibizumab; Young patient

Year:  2015        PMID： 26858482      PMCID： PMC4705195          DOI： 10.1016/j.mjafi.2014.11.009

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN： 0377-1237


× No keyword cloud information.
  10 in total

1.  Transpupillary thermotherapy for idiopathic subfoveal choroidal neovascularization.

Authors:  Atul Kumar; Gunjan Prakash; Rajindra P Singh
Journal:  Acta Ophthalmol Scand       Date:  2004-04

2.  Intravitreal bevacizumab for idiopathic choroidal neovascularization.

Authors:  Mehmet Cakir; Osman Cekiç; O Faruk Yilmaz
Journal:  J AAPOS       Date:  2009-03-14       Impact factor: 1.220

3.  Results of 1-year follow-up examinations after intravitreal bevacizumab administration for idiopathic choroidal neovascularization.

Authors:  Maiko Inoue; Kazuaki Kadonosono; Yoichiro Watanabe; Shimpei Sato; Satoshi Kobayashi; Shin Yamane; Rieko Ito; Akira Arakawa
Journal:  Retina       Date:  2010-05       Impact factor: 4.256

4.  The natural history of idiopathic subfoveal choroidal neovascularization.

Authors:  A C Ho; L A Yannuzzi; K Pisicano; J DeRosa
Journal:  Ophthalmology       Date:  1995-05       Impact factor: 12.079

5.  Etiology of choroidal neovascularization in young patients.

Authors:  S Y Cohen; A Laroche; Y Leguen; G Soubrane; G J Coscas
Journal:  Ophthalmology       Date:  1996-08       Impact factor: 12.079

Review 6.  Anti-VEGF compounds in the treatment of neovascular age related macular degeneration.

Authors:  C Campa; S P Harding
Journal:  Curr Drug Targets       Date:  2011-02       Impact factor: 3.465

7.  Intravitreal bevacizumab for subfoveal idiopathic choroidal neovascularization.

Authors:  Subrata Mandal; Satpal Garg; Pradeep Venkatesh; Charu Mithal; Rajpal Vohra; Abhas Mehrotra
Journal:  Arch Ophthalmol       Date:  2007-11

8.  The prognosis of idiopathic choroidal neovascularization in persons younger than 50 years of age.

Authors:  B Lindblom; T Andersson
Journal:  Ophthalmology       Date:  1998-10       Impact factor: 12.079

9.  Age-related macular degeneration.

Authors:  Hanna R Coleman; Chi-Chao Chan; Frederick L Ferris; Emily Y Chew
Journal:  Lancet       Date:  2008-11-22       Impact factor: 79.321

Review 10.  A safety review and meta-analyses of bevacizumab and ranibizumab: off-label versus goldstandard.

Authors:  Christine Schmucker; Christoph Ehlken; Hansjuergen T Agostini; Gerd Antes; Gerta Ruecker; Monika Lelgemann; Yoon K Loke
Journal:  PLoS One       Date:  2012-08-03       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.